Company Snapshot: MGT  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Medicsight to Present New Data at Major Radiology Conference
 

NEW YORK, Dec. 1 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (Amex: MGT), and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software, today announced that it will present a study abstract at the annual meeting of the Radiological Society of North America (RSNA) in Chicago on November 30 to December 5, 2008, the major radiology event of the year.

The presentation demonstrates that CAD increased the sensitivity for the detection of colorectal cancers in multi-row detector CT (MDCT) colonography (CTC) and that when both expert and non-expert CTC readers used CAD it increased their sensitivity in detecting colorectal cancers. Medicsight will present data from this study and from additional abstracts that demonstrate the clinical relevance of CAD in early detection of colorectal cancer. Medicsight will be showcasing its CAD products at both its partners' and its own exhibition booths. Medicsight's booth number at RSNA is no. 4076 -- Hall A, South Building.

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc is a technology holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange PLC.

Medicsight PLC (AIM: MDST) is a UK-headquartered, research driven, leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. The CAD software automatically highlights suspicious areas on computerized tomography (CT) scans of the colon and lung, helping radiologists to identify, measure and analyze potential disease and early indicators of disease. Medicsight's CAD software has been validated using one of the world's largest and most population diverse databases of verified patient CT scan data. Medicsight's ColonCAD(TM) and LungCAD(TM) software products are seamlessly integrated with the advanced 3D visualisation workstations of several industry-leading imaging equipment partners.

Medicexchange PLC provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing.

Additional information can be found at www.mgtci.com.

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.


SOURCE MGT Capital Investments, Inc.